U.S. market Closed. Opens in 16 hours 55 minutes

ANVS | Annovis Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
RevenueN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/A
Operating Expenses45.04M25.51M14.50M5.48M870.55K713.94K682.43K
Selling, General & Admin6.24M9.00M6.06M3.59M829.37K602.33K409.06K
Research & Development38.79M16.52M8.48M3.05M776.26K111.61K273.37K
Other Operating ExpensesN/AN/A-36.75K-1.16M-735.08KN/AN/A
Operating Income-45.04M-25.51M-14.54M-6.64M-1.61M-713.94K-682.43K
Other Expenses / Income-11.17M182.71K50.09K1.18M614.64K66.0084.00
Before Tax Income-56.20M-25.33M-14.49M-5.46M-990.98K-713.87K-682.35K
Income Tax Expenses-45.03K-182.71K-50.09K-1.20M-694.14K-132.00N/A
Net Income-56.20M-25.15M-14.44M-4.26M-296.84K-713.87K-682.35K
Interest ExpensesN/A-182.71KN/A47.23M-40.93M66.0084.00
Basic Shares Outstanding9.02M8.16M7.63M6.31M6.85M4.40M4.39M
Diluted Shares Outstanding9.02M8.16M7.63M6.31M6.85M4.40M4.39M
EBITDA-45.04M-25.51M-14.50M-5.46M-791.05K-713.94K-682.26K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-56.25M-25.51M-14.49M41.76M-41.92M-713.94K-682.26K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙